Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy
{{output}}
Despite advances in the development of new therapeutic agents and diagnostic imaging techniques, the 5-year survival of osteosarcoma, the most common type of bone cancer, remains practically unaltered for the last three decades at around 60%. Nanoparticle-base... ...
